Xylem Inc. has initiated a $1.5 billion share repurchase program, effective immediately following a 5.51% drop in stock price to $132.46. This decline follows disappointing revenue guidance for 2026, forecasted between $9.1 billion and $9.2 billion, which fell short of Wall Street expectations, contributing to a plunge of up to 10% in shares. Despite these challenges, Xylem reported a revenue growth of 7.79% for the previous fiscal year and boasts a market cap of $31.3 billion.